ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,096Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 393

$489K Total Retail Price of All Prescriptions

Rank: 66 out of 393

874 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 874 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,932 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 962 842 1 1
LISINOPRIL 901 765 2 2
OMEPRAZOLE 770 598 3 6
LEVOTHYROXINE SODIUM 596 513 4 3
ALENDRONATE SODIUM 487 462 5 16
HYDROCODONE-ACETAMINOPHEN 420 311 S3 6 5
AMLODIPINE BESYLATE 394 378 7 4
METFORMIN HCL 339 282 8 7
FUROSEMIDE 322 271 9 8
LOVASTATIN 322 296 9 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 309 290 11 24
ATENOLOL 276 223 12 13
METOPROLOL SUCCINATE 248 228 13 22
WARFARIN SODIUM 205 173 14 17
METOPROLOL TARTRATE 199 175 15 9
VENTOLIN HFA 195 172 16 42
POTASSIUM CHLORIDE 187 155 17 20
GABAPENTIN 172 120 18 15
HYDROCHLOROTHIAZIDE 163 127 19 10
GLIPIZIDE ER 154 133 20 76
SERTRALINE HCL 150 115 21 28
CLONIDINE HCL 139 110 22 50
LOSARTAN POTASSIUM 123 113 23 12
CITALOPRAM HBR 122 121 24 23
GEMFIBROZIL 121 106 25 62
FINASTERIDE 118 106 26 60
GLIPIZIDE 117 104 27 32
GLYBURIDE 116 113 R 28 46
TRAZODONE HCL 112 80 29 47
PLAVIX 108 103 30 51
IBUPROFEN 105 72 31 55
QVAR 105 98 31 101
ZOLPIDEM TARTRATE 104 88 33 11
DIGOXIN 103 96 34 66
TAMSULOSIN HCL 97 87 35 25
CARVEDILOL 97 84 35 21
LOSARTAN-HYDROCHLOROTHIAZIDE 89 89 37 31
TRIAMTERENE-HCTZ 88 76 38 49
TERAZOSIN HCL 87 81 39 38
PRAVASTATIN SODIUM 85 79 40 18
RANITIDINE HCL 83 75 41 29
FLUOXETINE HCL 78 57 42 37
LANTUS SOLOSTAR 76 45 43 74
CLOPIDOGREL 72 64 44 33
ISOSORBIDE MONONITRATE ER 72 72 44 67
DONEPEZIL HCL 71 71 46 34
MELOXICAM 69 67 47 58
AMITRIPTYLINE HCL 69 58 R 47 72
ALLOPURINOL 69 49 47 26
FENOFIBRATE 63 60 50 43
FLUTICASONE PROPIONATE 61 48 51 27
DILTIAZEM 24HR ER 59 59 52 129
ATORVASTATIN CALCIUM 57 35 53 19
TRAMADOL HCL 57 45 53 30
KLOR-CON 10 56 50 55 113
GLIMEPIRIDE 55 42 56 39
HYDRALAZINE HCL 53 35 57 64
PEN NEEDLE 53 44 57 81
NIFEDIPINE ER 52 38 59 91
BENAZEPRIL HCL 51 48 60 40
KLOR-CON M10 50 43 61 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.